[SGLT inhibitor (T-1095)].
Saito
Akira
A
Discovery Research Laboratory.
Seiyaku
Tanabe
T
Tsujihara
Kenji
K
D000818:Animals; D002254:Carbonates / Q000494:pharmacology / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D004195:Disease Models, Animal; D015195:Drug Design; D004734:Energy Metabolism; D005947:Glucose / Q000378:metabolism; D005960:Glucosides / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007003:Hypoglycemia / Q000188:drug therapy; D007004:Hypoglycemic Agents; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007668:Kidney / Q000378:metabolism; D009004:Monosaccharide Transport Proteins / Q000037:antagonists & inhibitors*
D002254:Carbonates; D005960:Glucosides; D007004:Hypoglycemic Agents; D007328:Insulin; D009004:Monosaccharide Transport Proteins; C121396:T 1095; D005947:Glucose